DNAprint Genomics (DNAG)

[frogdreaming]

Question.

Why does the filing list a maximum price for the share registration?

The price is set at .17 cents. Does that mean that DNAG expects the pps to remain below that value for the duration of the registration period?

If the pps goes higher than that, will the shares still be transacted at a maximum price of .17 cents or will there need to be a new filing to accomodate a higher price? One would hope that if the pps exceeded that value, then Dutchess would have to buy the shares at a discount to market price and not the fixed price from the filing.

Obviously if the pps is expected to stay below .17 cents for the duration of the filing period, then the upper limit value is irrelevant and can be ignored. The filing already allows for many more shares to be transacted than would be required for such a value, and so a lower trending share price has already been factored into the process by management. However, if there was any expectation of a higher pps, why wouldn't there be some mechanism for taking advantage of it? Perhaps a shorter term filing or a series of filings for much smaller amounts.

Just curious.
frog